265 related articles for article (PubMed ID: 27039088)
1. Naïve-pooled pharmacokinetic analysis of pyrazinamide, isoniazid and rifampicin in plasma and cerebrospinal fluid of Vietnamese children with tuberculous meningitis.
Pouplin T; Bang ND; Toi PV; Phuong PN; Dung NH; Duong TN; Caws M; Thwaites GE; Tarning J; Day JN
BMC Infect Dis; 2016 Apr; 16():144. PubMed ID: 27039088
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitis.
Ruslami R; Gafar F; Yunivita V; Parwati I; Ganiem AR; Aarnoutse RE; Wilffert B; Alffenaar JC; Nataprawira HM
Arch Dis Child; 2022 Jan; 107(1):70-77. PubMed ID: 34183327
[TBL] [Abstract][Full Text] [Related]
3. Effect of steroids on cerebrospinal fluid penetration of antituberculous drugs in tuberculous meningitis.
Kaojarern S; Supmonchai K; Phuapradit P; Mokkhavesa C; Krittiyanunt S
Clin Pharmacol Ther; 1991 Jan; 49(1):6-12. PubMed ID: 1988241
[TBL] [Abstract][Full Text] [Related]
4. Population Pharmacokinetic Properties of Antituberculosis Drugs in Vietnamese Children with Tuberculous Meningitis.
Panjasawatwong N; Wattanakul T; Hoglund RM; Bang ND; Pouplin T; Nosoongnoen W; Ngo VN; Day JN; Tarning J
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33139294
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid concentrations of antituberculosis agents in adults and children.
Donald PR
Tuberculosis (Edinb); 2010 Sep; 90(5):279-92. PubMed ID: 20709598
[TBL] [Abstract][Full Text] [Related]
6. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children.
Thwaites G; Fisher M; Hemingway C; Scott G; Solomon T; Innes J;
J Infect; 2009 Sep; 59(3):167-87. PubMed ID: 19643501
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
Mukherjee A; Velpandian T; Singla M; Kanhiya K; Kabra SK; Lodha R
Int J Tuberc Lung Dis; 2016 May; 20(5):666-72. PubMed ID: 27084822
[TBL] [Abstract][Full Text] [Related]
8. The chemotherapy of tuberculous meningitis in children and adults.
Donald PR
Tuberculosis (Edinb); 2010 Nov; 90(6):375-92. PubMed ID: 20810322
[TBL] [Abstract][Full Text] [Related]
9. Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis.
Thwaites GE; Bhavnani SM; Chau TT; Hammel JP; Török ME; Van Wart SA; Mai PP; Reynolds DK; Caws M; Dung NT; Hien TT; Kulawy R; Farrar J; Ambrose PG
Antimicrob Agents Chemother; 2011 Jul; 55(7):3244-53. PubMed ID: 21502621
[TBL] [Abstract][Full Text] [Related]
10. Intensive short course chemotherapy for tuberculous meningitis.
Jacobs RF; Sunakorn P; Chotpitayasunonah T; Pope S; Kelleher K
Pediatr Infect Dis J; 1992 Mar; 11(3):194-8. PubMed ID: 1565533
[TBL] [Abstract][Full Text] [Related]
11. Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial.
Heemskerk D; Day J; Chau TT; Dung NH; Yen NT; Bang ND; Merson L; Olliaro P; Pouplin T; Caws M; Wolbers M; Farrar J
Trials; 2011 Feb; 12():25. PubMed ID: 21288325
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of levofloxacin versus rifampicin in tuberculous meningitis: an open-label randomized controlled trial.
Kalita J; Misra UK; Prasad S; Bhoi SK
J Antimicrob Chemother; 2014 Aug; 69(8):2246-51. PubMed ID: 24752957
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of additional levofloxacin in tuberculous meningitis: A randomized controlled pilot study.
Kalita J; Bhoi SK; Betai S; Misra UK
Tuberculosis (Edinb); 2016 May; 98():1-6. PubMed ID: 27156611
[TBL] [Abstract][Full Text] [Related]
14. Three chemotherapy studies of tuberculous meningitis in children.
Ramachandran P; Duraipandian M; Nagarajan M; Prabhakar R; Ramakrishnan CV; Tripathy SP
Tubercle; 1986 Mar; 67(1):17-29. PubMed ID: 3715980
[TBL] [Abstract][Full Text] [Related]
15. Pediatric tuberculous meningitis: Model-based approach to determining optimal doses of the anti-tuberculosis drugs rifampin and levofloxacin for children.
Savic RM; Ruslami R; Hibma JE; Hesseling A; Ramachandran G; Ganiem AR; Swaminathan S; McIlleron H; Gupta A; Thakur K; van Crevel R; Aarnoutse R; Dooley KE
Clin Pharmacol Ther; 2015 Dec; 98(6):622-9. PubMed ID: 26260983
[TBL] [Abstract][Full Text] [Related]
16. Optimizing Dosing and Fixed-Dose Combinations of Rifampicin, Isoniazid, and Pyrazinamide in Pediatric Patients With Tuberculosis: A Prospective Population Pharmacokinetic Study.
Denti P; Wasmann RE; van Rie A; Winckler J; Bekker A; Rabie H; Hesseling AC; van der Laan LE; Gonzalez-Martinez C; Zar HJ; Davies G; Wiesner L; Svensson EM; McIlleron HM
Clin Infect Dis; 2022 Aug; 75(1):141-151. PubMed ID: 34665866
[TBL] [Abstract][Full Text] [Related]
17. Hepatic toxicity in South Indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamide.
Parthasarathy R; Sarma GR; Janardhanam B; Ramachandran P; Santha T; Sivasubramanian S; Somasundaram PR; Tripathy SP
Tubercle; 1986 Jun; 67(2):99-108. PubMed ID: 3775870
[TBL] [Abstract][Full Text] [Related]
18. Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis.
Galileya LT; Wasmann RE; Chabala C; Rabie H; Lee J; Njahira Mukui I; Hesseling A; Zar H; Aarnoutse R; Turkova A; Gibb D; Cotton MF; McIlleron H; Denti P
PLoS Med; 2023 Nov; 20(11):e1004303. PubMed ID: 37988391
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of dried blood spot sampling for pharmacokinetic research and therapeutic drug monitoring of anti-tuberculosis drugs in children.
Martial LC; Kerkhoff J; Martinez N; Rodríguez M; Coronel R; Molinas G; Roman M; Gomez R; Aguirre S; Jongedijk E; Huisman J; Touw DJ; Pérez D; Chaparro G; Gonzalez F; Aarnoutse RE; Alffenaar JW; Magis-Escurra C
Int J Antimicrob Agents; 2018 Jul; 52(1):109-113. PubMed ID: 29751121
[TBL] [Abstract][Full Text] [Related]
20. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial.
Ruslami R; Ganiem AR; Dian S; Apriani L; Achmad TH; van der Ven AJ; Borm G; Aarnoutse RE; van Crevel R
Lancet Infect Dis; 2013 Jan; 13(1):27-35. PubMed ID: 23103177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
